BRCA1 and BRCA2 Gene Mutations and Lung Cancer Sisk: A Meta-Analysis.
Conclusion: With the limitation of the retrospective study design and severe heterogeneity, these results inform clinicians and relevant families that BRCA1 and BRCA2 mutation carriers have no increased risk of lung cancer.
PMID: 32349445 [PubMed - in process]
Source: Medicina (Kaunas) - Category: Universities & Medical Training Authors: Lee YC, Lee YC, Li CY, Lee YL, Chen BL Tags: Medicina (Kaunas) Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | Lung Cancer | Ovarian Cancer | Ovaries | Study | Universities & Medical Training